Legend Biotech Corporation (LEGN) revealed Loss for its second quarter of -$125.380 million
The company's bottom line came in at -$125.380 million, or -$0.34 per share. This compares with -$18.196 million, or -$0.05 per share, last year.
The company's revenue for the period rose 36.7% to $255.058 million from $186.523 million last year.
Legend Biotech Corporation earnings at a glance (GAAP) :
-Earnings: -$125.380 Mln. vs. -$18.196 Mln. last year.-EPS: -$0.34 vs. -$0.05 last year.-Revenue: $255.058 Mln vs. $186.523 Mln last year.
Excluding items, income was $10.091 million, or $0.03 per share, compared with a loss of $2.057 million, or $0.01 per share, in the same period last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.